A detailed history of Morgan Stanley transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Morgan Stanley holds 763,471 shares of LNTH stock, worth $68.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
763,471
Previous 685,597 11.36%
Holding current value
$68.2 Million
Previous $55 Million 52.22%
% of portfolio
0.01%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$77.7 - $123.62 $6.05 Million - $9.63 Million
77,874 Added 11.36%
763,471 $83.8 Million
Q2 2024

Oct 17, 2024

BUY
$58.87 - $83.05 $2.57 Million - $3.63 Million
43,676 Added 6.8%
685,597 $55 Million
Q2 2024

Aug 14, 2024

BUY
$58.87 - $83.05 $2.57 Million - $3.63 Million
43,676 Added 6.8%
685,597 $55 Million
Q1 2024

Oct 17, 2024

SELL
$51.07 - $68.26 $2.23 Million - $2.98 Million
-43,676 Reduced 6.37%
641,921 $40 Million
Q1 2024

Aug 16, 2024

BUY
$51.07 - $68.26 $1.26 Million - $1.69 Million
24,763 Added 4.01%
641,921 $40 Million
Q1 2024

May 15, 2024

BUY
$51.07 - $68.26 $1.26 Million - $1.69 Million
24,763 Added 4.01%
641,921 $40 Million
Q4 2023

Aug 16, 2024

SELL
$55.6 - $77.89 $3.81 Million - $5.33 Million
-68,439 Reduced 9.98%
617,158 $38.3 Million
Q4 2023

Feb 13, 2024

BUY
$55.6 - $77.89 $4.8 Million - $6.72 Million
86,271 Added 16.25%
617,158 $38.3 Million
Q3 2023

Nov 15, 2023

SELL
$60.27 - $90.75 $19.8 Million - $29.8 Million
-328,307 Reduced 38.21%
530,887 $36.9 Million
Q2 2023

Aug 14, 2023

BUY
$82.41 - $99.65 $11.9 Million - $14.4 Million
144,029 Added 20.14%
859,194 $72.1 Million
Q1 2023

May 15, 2023

BUY
$47.76 - $82.86 $5.17 Million - $8.97 Million
108,201 Added 17.83%
715,165 $59 Million
Q4 2022

Feb 14, 2023

SELL
$48.76 - $77.67 $14.5 Million - $23.1 Million
-297,004 Reduced 32.86%
606,964 $30.9 Million
Q3 2022

Nov 14, 2022

SELL
$61.42 - $86.29 $2.87 Million - $4.03 Million
-46,678 Reduced 4.91%
903,968 $63.6 Million
Q2 2022

Oct 27, 2022

BUY
$55.54 - $72.65 $28.2 Million - $36.9 Million
508,203 Added 114.86%
950,646 $62.8 Million
Q2 2022

Aug 15, 2022

BUY
$55.54 - $72.65 $28.2 Million - $36.9 Million
508,203 Added 114.86%
950,646 $62.8 Million
Q1 2022

Oct 27, 2022

SELL
$24.28 - $56.64 $12.3 Million - $28.8 Million
-508,203 Reduced 53.46%
442,443 $24.5 Million
Q1 2022

May 13, 2022

BUY
$24.28 - $56.64 $1.95 Million - $4.56 Million
80,461 Added 22.23%
442,443 $24.5 Million
Q4 2021

Feb 14, 2022

BUY
$22.54 - $30.44 $1.42 Million - $1.92 Million
63,077 Added 21.1%
361,982 $10.5 Million
Q3 2021

Nov 15, 2021

BUY
$24.23 - $28.59 $7.24 Million - $8.55 Million
298,905 New
298,905 $7.68 Million

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $6.14B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.